We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+16.06%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7.88B
AUM Growth
+$967M
Cap. Flow
-$59.3M
Cap. Flow %
-0.75%
Top 10 Hldgs %
72.68%
Holding
127
New
5
Increased
26
Reduced
38
Closed
14

Sector Composition

Rank Sector Weight
1 Financials 22.43%
2 Consumer Discretionary 16.91%
3 Healthcare 14.47%
4 Consumer Staples 10.11%
5 Communication Services 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDOC icon
51
Teladoc Health
TDOC
$1.69B
$5.83M 0.07%
104,834
+46,827
+81% +$2.86M
PTLA
52
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$5.53M 0.07%
159,366
TSM icon
53
TSMC
TSM
$1.97T
$5.49M 0.07%
134,052
+303
+0.2% +$11.6K
NVCR icon
54
NovoCure
NVCR
$1.81B
$5.21M 0.07%
108,059
-33,035
-23% -$1.59M
EXAS
55
DELISTED
Exact Sciences
EXAS
$5.11M 0.06%
58,932
-9,399
-14% -$800K
HZNP
56
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.06M 0.06%
191,544
LHCG
57
DELISTED
LHC Group LLC
LHCG
$5.06M 0.06%
45,657
+8,000
+21% +$854K
PODD icon
58
Insulet
PODD
$11.7B
$5.01M 0.06%
52,672
+26,678
+103% +$2.29M
VCRA
59
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$4.9M 0.06%
155,058
+120,045
+343% +$4.26M
CI icon
60
Cigna
CI
$78.9B
$4.83M 0.06%
30,018
-23,807
-44% -$4.35M
TXMD icon
61
TherapeuticsMD
TXMD
$23.6M
$4.82M 0.06%
19,797
+5,759
+41% +$1.52M
STML
62
DELISTED
Stemline Therapeutics, Inc.
STML
$4.6M 0.06%
358,082
+225,654
+170% +$2.55M
ILMN icon
63
Illumina
ILMN
$29.1B
$4.51M 0.06%
+14,911
New +$4.35M
DERM
64
DELISTED
Dermira, Inc.
DERM
$4.4M 0.06%
324,884
+21,932
+7% +$183K
ONCE
65
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$4.26M 0.05%
37,392
-4,232
-10% -$311K
JAZZ icon
66
Jazz Pharmaceuticals
JAZZ
$16B
$4.26M 0.05%
29,774
-2,290
-7% -$299K
AIMT
67
DELISTED
Aimmune Therapeutics
AIMT
$4.08M 0.05%
182,709
+48,377
+36% +$1.14M
XENT
68
DELISTED
Intersect ENT, Inc
XENT
$3.97M 0.05%
123,514
GWPH
69
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.96M 0.05%
23,473
-2,229
-9% -$332K
DVAX
70
DELISTED
Dynavax Technologies
DVAX
$3.63M 0.05%
496,412
+6,049
+1% +$59.1K
COLL icon
71
Collegium Pharmaceutical
COLL
$1.18B
$3.57M 0.05%
236,021
GKOS icon
72
Glaukos
GKOS
$9.19B
$3.47M 0.04%
44,265
-5,010
-10% -$335K
INCY icon
73
Incyte
INCY
$25.4B
$3.33M 0.04%
38,726
-5,753
-13% -$468K
INSM icon
74
Insmed
INSM
$22.7B
$3.29M 0.04%
113,110
DXCM icon
75
DexCom
DXCM
$29.1B
$3.21M 0.04%
107,796

Similar funds

C WorldWide Group's Q1 2019 Portfolio in Review

As of Q1 2019, C WorldWide Group held 127 positions worth $7.88B, up 14% from $6.91B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

C WorldWide Group's Q1 2019 filing shows 5 new, 26 increased, 38 reduced and 14 closed positions. Its largest new stake was LivaNova: 83,163 shares worth $8.09M. The largest sale was Meta Platforms (Facebook), an estimated $330M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • C WorldWide Group's largest Q1 2019 buy was LivaNova: 83,163 shares worth $8.09M.
  • C WorldWide Group added most to Microsoft in Q1 2019, an estimated $343M increase.
  • C WorldWide Group's biggest Q1 2019 reduction was Visa, cutting an estimated $15.4M.
  • C WorldWide Group fully exited Meta Platforms (Facebook) in Q1 2019, selling an estimated $330M.
  • C WorldWide Group's ten largest holdings make up 73% of its $7.88B portfolio in Q1 2019.
  • C WorldWide Group opened 5 new positions and closed 14 in Q1 2019.
  • C WorldWide Group's portfolio value rose 14% quarter-over-quarter to $7.88B.

Based on C WorldWide Group's 13F filing for Q1 2019, filed 3 May 2019.